[Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
Hiroaki Yamanaka, Kazuhiro Iwase(Osaka Prefectural Medical Center), Toshikazu Ito, Toshiya Michiura, Satoshi Kainuma(National Cerebral and Cardiovascular Center), Haruki Ide, Kentaro Nonaka(Mannari Hospital), Shoki Mikata, Tsunekazu Mizushima(The University of Osaka)
PubMed
December 1, 2005
Cited by 0
Related Papers
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
|Frontiers in Cardiovascular Medicine|2022|106
IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice
|Scientific Reports|2017|105
Annual report on National Clinical Database 2020 for gastroenterological surgery in Japan
|Annals of Gastroenterological Surgery|2023|94
Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer
|Cancer Chemotherapy and Pharmacology|2014|87
2023 National Clinical Database Annual Report by the Japan Surgical Society
|Surgery Today|2025|79